Quia Pharma AB
0
0
+SEK0.00+0% 00:00 Hari ini
Statistik
Tertinggi harian
-
Paras terendah hari ini
-
Tertinggi 52M
-
Paras terendah 52M
-
Volum
-
Vol. purata
-
Kap. pasaran
0
Nisbah P/E
-
Hasil dividen
-
Dividen
-
Pesaing
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ia bukan cadangan pelaburan.
Perihal
Quia Pharma AB (publ) engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform. The company develops drugs through its pegylation technology platform. Its product pipeline includes QPG-1030 (pegylated teduglutide) for the treatment of short bowel syndrome, and QPG-1029 under pre-clinical development for stable plasma concentration, as well as antibody-drug conjugates being developed using the company's Uni-Qleaver technology-platform. The company was formerly known as QuiaPEG Pharmaceuticals Holding AB (publ) and changed its name to Quia Pharma AB (publ). Quia Pharma AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
Tunjukkan lagi
CEO
Dr. Vidar Wendel-Hansen M.D., Ph.D.
Pekerja
2
Negara
Sweden
ISIN
SE0023849716
Penyenaraian
0 Komen
Kongsi pendapat anda
Soalan Lazim
Apakah simbol saham Quia Pharma AB?▼
Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa Stockholm Exchange, saham Quia Pharma AB didagangkan di bawah simbol QUIA-BT-UN.ST.
Berapa ramai pekerja yang dimiliki oleh Quia Pharma AB?▼
Sehingga 8 Oktober 2026, syarikat mempunyai 2 pekerja.
Quia Pharma AB terletak dalam sektor apa?▼
Quia Pharma AB beroperasi dalam sektor Kesihatan & Kesejahteraan.
Bilakah Quia Pharma AB menyiapkan split saham?▼
Quia Pharma AB tidak mempunyai sebarang split baru-baru ini.
Di manakah ibu pejabat Quia Pharma AB?▼
Ibu pejabat Quia Pharma AB terletak di Uppsala, Sweden.